Amidase encapsulated O-carboxymethyl chitosan nanoparticles for vaccine delivery.

[1]  S. Bertholet,et al.  Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials , 2012, Front. Cell. Inf. Microbio..

[2]  K. Chennazhi,et al.  Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells , 2011 .

[3]  S. Nair,et al.  Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N,O-carboxymethyl chitosan nanoparticles , 2009 .

[4]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[5]  A. Almeida,et al.  The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles. , 2009, Biomaterials.

[6]  O. Schneewind,et al.  Vaccine assembly from surface proteins of Staphylococcus aureus , 2006, Proceedings of the National Academy of Sciences.

[7]  F. Götz,et al.  Activity of the major staphylococcal autolysin Atl. , 2006, FEMS microbiology letters.

[8]  J. Irache,et al.  A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. , 2001, Vaccine.

[9]  O. Schneewind,et al.  Targeting of muralytic enzymes to the cell division site of Gram‐positive bacteria: repeat domains direct autolysin to the equatorial surface ring of Staphylococcus aureus , 1998, The EMBO journal.

[10]  G. Archer.  Staphylococcus aureus: a well-armed pathogen. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.